Chuan Shen

Dr. Chuan Shen

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2014 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CSChuan Shen
Chuan Shen
CZCaiyan Zhao
Caiyan Zhao
WWWei Wang
Wei Wang
YWYadong Wang
Yadong Wang
HSHui Sun
Hui Sun
JGJian Gao
Jian Gao
The relationship between resistin and non-alcoholic steatohepatitis (NASH) is not clear, some studies claimed that serum resistin levels were associated with neither the presence of NASH nor its severity, others declared that serum resistin was related with inflammation and fibrosis in NASH. Our animal study verified that the distribution of resistin in the liver is correlated with inflammation in NASH. However, there is no pertinent study in humans. Thirty patients with NASH, 28 simple steatosis, and 43 controls were recruited. Blood was collected for resistin, liver chemistries, fasting insulin and some metabolic parameters. Liver histology was scored according to NAFLD activity scoring system. Hepatic resistin expression was examined by real-time polymerase chain reaction, immunohistochemistry. Resistin protein expression was confirmed by western blotting in 13 patients with concomitant NAFLD and gallstone. Serum resistin was significantly elevated in both NASH and simple steatotic subjects compared with controls (all P < 0.05). Hepatic resistin was significantly increased in NASH patients in both mRNA and protein levels than those in simple steatosis and control subjects (all P < 0.05). Both serum and hepatic resistin had a correlation with obesity, but not with insulin resistance. The distribution of resistin positive cells was predominantly in perisinusoidal cells (such as Kupffer cells and hepatic stellate cells) in human NASH. Multivariate analysis revealed that waist-hip ratio, higher serum triglyceride, and hyperresistinemia were independent factors related to higher grade of steatosis; whereas hepatic resistin and serum cytokeratin predict NASH and severity of liver fibrosis. Hepatic resistin overexpression in NASH patients is associated with the severity of liver inflammation and fibrosis. Liver-derived resistin may be involved in the pathogenesis of human NASH.


14 August 2010 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CSChuan Shen
Chuan Shen
CZCaiyan Zhao
Caiyan Zhao
FLFang Liu
Fang Liu
YWYadong Wang
Yadong Wang
JYJun Yu
Jun Yu
Thiamazole is a widely used antithyroid agent that has been approved for the treatment of hyperthyroidism. Although thiamazole-induced hepatotoxicity is a main side effect, it may progress to liver failure in a very few cases.

10 December 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
XZXiaotong Zhang
Xiaotong Zhang
CZCe Zhang
Ce Zhang
MLMengyao Lv
Mengyao Lv
SWShu Wang
Shu Wang
QWQiuting Wang
Qiuting Wang
CSChuan Shen
Chuan Shen
Background: Carbapenem-resistant Gram-negative bacteria (CRGNB) pose a severe global health threat, yet comprehensive bibliometric analyses in this field remain limited. This systematic review employs a bibliometric methodology to identify research hotspots and emerging trends from 2020 to 2025. Method: Literature published between January 1, 2020, and October 31, 2025, was retrieved from the Web of Science Core Collection (WoSCC), Scopus, and PubMed for bibliometric analysis. Analytical tools, including VOSviewer, CiteSpace, and the Bibliometrix package, were used to assess publications by number, country, institution, journal, author, and keywords. Results: The bibliometric analysis revealed that global CRGNB research has experienced a fluctuating growth trend. China was the leading contributor, with 2,950 publications (25.5% of the total), and demonstrated significant collaboration with the USA and the UK. Major research clusters encompassed hypervirulent CRGNB strains (particularly carbapenem-resistant Klebsiella pneumoniae and Escherichia coli ), resistance mechanisms (particularly carbapenemase-producing), antibiotic resistance, emerging therapeutic strategies (such as novel β-lactam/β-lactamase inhibitors, siderophore antibiotics, phage therapy, and antimicrobial peptides) and One Health perspectives (addressing environmental reservoirs). Thematic analysis identified evolving research priorities, including hypervirulent CRGNB strains, artificial intelligence, and early diagnosis and rapid screening of carbapenem resistance, exemplified by clustered regularly interspaced short palindromic repeats-based detection and artificial intelligence-driven matrix assisted laser desorption ionization-time of flight analysis. Randomized controlled trials indicated promising outcomes for several new antimicrobial agents, such as cefiderocol, sulbactam-durlobactam, and imipenem-relebactam. However, safety concerns, particularly in critically ill patients, remain a significant challenge. Conclusion: CRGNB research is increasingly directed toward elucidating resistance mechanisms, improving diagnostic tools, and exploring non-antibiotic therapeutic options. Strengthening international collaboration and fostering multidisciplinary approaches are imperative to advance high-quality research and address this growing threat.

30 October 2025 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
PDF file
CZCe Zhang
Ce Zhang
MLMengyao Lv
Mengyao Lv
XZXiaotong Zhang
Xiaotong Zhang
SWShu Wang
Shu Wang
CYChengshuai Yang
Chengshuai Yang
CSChuan Shen
Chuan Shen
Background: Cryptococcosis, while well-documented in immunocompromised hosts, remains a rare complication in myasthenia gravis (MG) patients undergoing immunosuppressive therapy. Methods: We reported three cases of cryptococcal infection in MG patients diagnosed via cryptococcal antigen (CrAg) testing and/or histopathology, coupled with a comprehensive literature review of 14 additional cases that highlights the diagnostic and therapeutic challenges in this population. We also explored potential immunodeficiency by whole-exome sequencing (WES). Results: The comibined cohort (median age 57.1 years) demonstrated predominant central nervous system (52.9%), pulmonary (47.1%), and cutaneous (23.5%) involvement, with disseminated disease correlating with markedly decreased CD4+ T cells counts. Diagnostic complexity arose from imaging findings mimicking malignancies. A heterozygous FAS mutation (p.S19L) was identified by WES in one of our patients; however, its association with cryptococcal infection remains unclear. Management required tailored antifungal regimens (amphotericin B, fluconazole, flucytosine) and careful therapeutic drug monitoring to address immunosuppressant interactions. Four patients received surgical management targeting the local lesions. Most cases achieved clinical resolution. Conclusion: The management of cryptococcal infection in patients with MG poses significant challenges in the context of underlying immune dysfunction and the use of immunosuppressive therapy. Within this complex clinical scenario, early recognition, multidisciplinary care, and individualized treatment strategies are paramount. They underscore the need for heightened clinical vigilance and further research to optimize outcomes in this vulnerable patient population.

16 July 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
YFYize Fan
Yize Fan
SWShu Wang
Shu Wang
XZXingyu Zhu
Xingyu Zhu
XZXiaotong Zhang
Xiaotong Zhang
CZCe Zhang
Ce Zhang
CSChuan Shen
Chuan Shen
Background: Staphylococcus aureus ( S. aureus ) has emerged as a significant global public health threat, owing to its complex immune evasion strategies. Despite growing research output in this field, a comprehensive, data-driven bibliometric analysis delineating its global landscape, research hotspots, and translational gaps remains lacking. Methods: Publications from 2006 to 2025 were retrieved from the Web of Science Core Collection (WOSCC) and Scopus databases, which formed the core dataset for bibliometric analysis. Clinical trial data were independently supplemented from PubMed to assess translational progress. Multidimensional bibliometric analyses and visualization were performed using R-bibliometrix, VOSviewer and CiteSpace. Results: A total of 1,374 eligible publications were included, with an average annual growth rate of 15.71%, indicating a rapidly expanding field. The research landscape exhibits a hierarchical, stepwise distribution dominated by the United States, with active contributions from multiple countries. Utrecht University and the University of California system were the most prolific institutions. Frontiers-series journals serve as the major publication outlets. Knowledge structure analysis indicates a paradigm shift from fundamental immune mechanisms toward antibiotic resistance, biofilm biology, and immunometabolic regulation. Integration of PubMed clinical data revealed a critical translational gap, as despite advances in mechanistic research, most candidate vaccines and monoclonal antibody therapies failed to meet primary clinical endpoints. Conclusion: Research on S. aureus immune evasion is transitioning from foundational mechanistic studies toward multi-omics integration and clinical translation. Future efforts should transcend single-target strategies, focusing on novel therapeutic approaches grounded in immunometabolic modulation and precision treatment regimens.